Immuno-oncology
EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026
2026-06-29
The Next Decade in Cancer Therapeutics: How Immunotherapy is Evolving from Efficacy to Precision
2026-05-05
Layoffs in Biotech and Pharma: A February 2025 Overview by Therapeutic and Technology Focus
2025-04-01
From Labs to Breakthroughs: HanchorBio Aims High in the Immuno-Oncology Market with HCB101
2025-02-17
Protect Bio, the Next Rising Star in the Blue Ocean Market of Companion Animals’ Healthcare
2022-11-29
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08
LATEST
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




